跳至主要内容
临床试验/ACTRN12614000158662
ACTRN12614000158662招募中4 期

Prevention of oral mucositis in pediatric patients with acute lymphoblastic leukemia undergoing chemotherapy: a randomized controlled, cross-over trial using 0.12% chlorhexidine gluconate and 1% povidone iodine mouthwash

Amanda Christina C. Dujua, MD0 个研究点目标入组 20 人开始时间: 2014年2月10日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • Children ages of 6 to 18 years old diagnosed with Acute Lymphoblastic Leukemia who are undergoing Induction, Consolidation, or Re-induction chemotherapy (based on the Modified Berlin-Frankfurt-Munster Acute Lymphoblastic Leukemia Protocol) or Induction or Intensification chemotherapy (based on the Children’s Cancer Group Protocol, CCG-1941: Bone Marrow Transplantation versus Prolonged Intensive Chemotherapy for Children with Acute Lymphoblastic Leukemia after an Initial Bone Marrow Relapse) and seeking consult at STUH-BCI, and are capable of tooth-brushing and mouth-rinsing as judged by the principal investigator

排除标准

  • Children with oral mucositis or any oral lesion at initial assessment.
  • Children with the following conditions: hypersensitivity to iodine, hyperthyroidism, mental retardation.

研究者

发起方
Amanda Christina C. Dujua, MD

相似试验